Submacular Injection of Ranibizumab as a New Surgical Treatment for Refractory Diabetic Macular Edema
Purpose. In this study, we describe a new surgical technique for the treatment of refractory DME. The technique consists of vitrectomy with ILM peeling with a subretinal injection of ranibizumab. Methods. This is a prospective interventional noncomparative study including patients with refractory DM...
Saved in:
Main Authors: | Samir M. El-Baha, Ahmed M. Abdel Hadi, Mahmoud A. Abouhussein |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2019/6274209 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of Vitrectomy with Planned Foveal Detachment as Surgical Treatment for Refractory Diabetic Macular Edema with or without Vitreomacular Interface Abnormality
by: Ahmed M. Abdel Hadi
Published: (2018-01-01) -
Comparison of Perioperative Ranibizumab Injections for Diabetic Macular Edema in Patients Undergoing Cataract Surgery
by: Erhan Yumuşak, et al.
Published: (2016-01-01) -
Renal Biomarkers for Treatment Effect of Ranibizumab for Diabetic Macular Edema
by: Ivan Pochou Lai, et al.
Published: (2020-01-01) -
Comparison of Intravitreal Aflibercept and Ranibizumab following Initial Treatment with Ranibizumab in Persistent Diabetic Macular Edema
by: Ali Demircan, et al.
Published: (2018-01-01) -
Choroidal Structural Changes of Posterior Subtenon Triamcinolone Acetonide Injection in Eyes with Refractory Diabetic Macular Edema
by: Bing Liu, et al.
Published: (2022-01-01)